The Ministry of Health announces that today, 3 April 2022:
- 2 deaths
- Related to:
- Female, aged 87 years, who died on 3 April
- Female, aged 76 years, who died on 3 April
- Total number of deaths with a terminal cause of COVID-19: 942.
- 203 COVID-19 patients were hospitalized in OCHS hospitals
- 27 in serious condition (ICU: 1 off ventilator/8 intubated, NICU: 18)
-
- Percentage of inpatients with no history of vaccination: 55.67%
- 14 patients who ceased to be infectious continue to be intubated due to COVID in an ICU.
Diagnostic tests:
- A total of 78,818 diagnostic tests
- 2,853 new cases were identified (total cases 439.802)
- Positivity rate in all tests 3.62%
Total number of molecular tests (PCR):[/B]
- 2.603 molecular tests
- 144positive cases
- Positivity rate 5.53%
Total number of rapid antigen detection tests (RapidTest):
- 76positive cases
- 76.215 rapid antigen detection tests
- 2.709 positive cases
- Positivity rate 3.55%
Tracing:
- 959 rapid antigen detection tests were performed and 82 positive cases were identified (positivity rate 8.55%)
Private initiative:
- 1.399 molecular tests, 83 positive cases detected (positivity rate 5.93%)
- 27,735 rapid antigen detection tests performed, 1.190 positive cases (positivity rate 4.29%)
48,480[/B] rapid antigen detection tests were performed through the Ministry of Health programmes. 1,519 1,519 positive cases were detected.
- Sampling points: 44,733 rapid detection tests were detected 1.430 positive cases (positivity rate 3.2%)
Other
- Welfare homes: 68 rapid antigen detection tests were performed, 2 positive cases were identified (positivity rate 2.94%)
- Closed structures: 2 rapid antigen detection tests were performed.720[/B] rapid antigen detection tests identified 5 new cases (positivity rate 0,18%).
Note:
The numbers reported in the communication are indicative and may vary based on final and updated data sent as part of the National Epidemiological Risk Report published every second Friday.
(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO
Source
